Dodecanoate

Dodecanoate

SCHEMBL4239059

CCCCCCCCCCCC(=O)O.CN(C)CCCN

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.61
PPARG P37231 7/20 0.61
PPARD Q03181 7/20 0.61
PPARA Q07869 7/20 0.61
HDAC11 Q96DB2 5/20 0.61
TSHR P16473 4/20 0.61
PTPN1 P18031 3/20 0.61
ALDH1A1 P00352 3/20 0.61
KMT2A Q03164 3/20 0.61
ALOX15 P16050 3/20 0.61
TLR2 O60603 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
FABP4 P15090 2/20 0.61
MEN1 O00255 2/20 0.61
HSD17B10 Q99714 2/20 0.61
SLC22A6 Q4U2R8 1/20 0.61
SLC22A8 Q8TCC7 1/20 0.61
ESR1 P03372 1/20 0.61
PDE4A P27815 1/20 0.61
PDE3A Q14432 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Myristic Acid SCHEMBL4244025 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL29072348 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Behenic Acid SCHEMBL2860357 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL689939 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Palmitic Acid SCHEMBL2858784 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL7783086 0.98 GPR84 (0.59) GPR84PPARGPPARDPPARAHDAC11
Hexanoate SCHEMBL29072341 0.98 AKR1B1 (0.59) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL28166526 0.91 GPR84 (0.59) GPR84PPARGPPARDPPARAHDAC11
Behenic Acid SCHEMBL2864700 0.91 GPR84 (0.63) GPR84PPARGPPARDPPARAHDAC11
Myristic Acid SCHEMBL2865131 0.91 GPR84 (0.63) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090030092-A1 THICKENING AGENT AJINOMOTO CO., INC. (JP) 2009-01-29 US claimed
US-12582590-B2 Transparent liquid composition and cosmetic containing said composition SEIWA KASEI COMPANY, LIMITED (JP) 2026-03-24 US disclosed
EP-4129411-A1 TRANSPARENT LIQUID COMPOSITION AND COSMETIC CONTAINING SAID COMPOSITION Seiwa Kasei Company, Limited (JP) 2023-02-08 EP disclosed
WO-2023008587-A1 WASHING METHOD ライオン株式会社 2023-02-02 WO disclosed
US-20230025852-A1 A TRANSPARENT LIQUID COMPOSITION AND COSMETIC CONTAINING SAID COMPOSITION SEIWA KASEI COMPANY, LIMITED (JP) 2023-01-26 US disclosed
CN-115397389-A Transparent liquid composition and cosmetic containing the same 株式会社成和化成 2022-11-25 CN disclosed
CN-110791964-B Treating agent for elastic fiber and elastic fiber 竹本油脂株式会社 2020-10-23 CN disclosed
CN-110868996-A Second agent for hair treatment agent and hair treatment agent 株式会社漫丹 2020-03-06 CN disclosed
CN-110791964-A Treating agent for elastic fiber and elastic fiber 竹本油脂株式会社 2020-02-14 CN disclosed
US-8187579-B2 Thickening agent AJINOMOTO CO., INC. (JP) 2012-05-29 US disclosed
US-20090030092-A1 THICKENING AGENT AJINOMOTO CO., INC. (JP) 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030092-A1 THICKENING AGENT CUTA, NAAA, ACOT7 GPR84 162/4885PPARG 1104/4885PPARD 2726/4885
US-20230025852-A1 A TRANSPARENT LIQUID COMPOSITION AND COSMETIC CONTAINING SAID COMPOSITION CUTA, UGCG, GK GPR84 1997/4885PPARG 276/4885PPARD 1376/4885
US-12582590-B2 Transparent liquid composition and cosmetic containing said composition GK, CUTA, GHDC GPR84 1497/4885PPARG 117/4885PPARD 1161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.